FDA Approves Generic GLP-1 Injection for Type 2 Diabetes
The FDA has approved a low-cost generic version of liraglutide, a GLP-1 medication, offering relief to patients with Type 2 diabetes amid ongoing shortages, The Hill reported.
The FDA has approved a low-cost generic version of liraglutide, a GLP-1 medication, offering relief to patients with Type 2 diabetes amid ongoing shortages, The Hill reported.
What's Your Reaction?
